As of November this year, based on Merit Medical Systems's latest financial report, the company's current EPS (TTM) is $2.01. In 2024, MMSI reported a per-share earnings of $2.07, which represents an increase compared to the EPS of $1.64 recorded in 2023. Merit Medical Systems's EPS for the quarterly period ending on Sep 30, 2025 was $0.47.
The yearly EPS in 2024 was $2.07, an increase of 26.2% compared to $1.64 recorded in 2023. For the quarter ending Sep 30, 2025, the EPS was $0.47, reflecting a 4.1% decline compared to the same quarter a year earlier. The trailing twelve months (TTM) EPS as of September 2025 is $2.01. In 2023, the annual EPS was $1.64, showing an increase of 25.2% compared to 2022.
Merit Medical Systems has recorded a decrease in earnings per share of 4.1% over the past 12 months (YoY, quarterly). For the last three years, MMSI had an average yearly EPS growth of 34%. Merit Medical Systems had an average annual EPS growth of 83.3% over the last five years. Over the last decade, MMSI had an average annual earnings per share growth of 14.6%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| EW Edwards Lifesciences Corp | 11.85 | 202.2% | 42.5% | 33% |
| JNJ Johnson & Johnson | 17.89 | -57.9% | -9.7% | 0.4% |
| MDT Medtronic plc | 24.8 | 31% | -1.1% | 0.3% |
| TFX Teleflex Inc | 29.2 | -80.3% | -47.6% | -31.7% |
| MMSI Merit Medical Systems Inc | 43.34 | 26.2% | 34% | 83.3% |
| BSX Boston Scientific Corp | 52.33 | 16.7% | 22.2% | -17.9% |
| ANGO Angiodynamics Inc | N/A | 81.9% | N/A | N/A |
| ICUI Icu Medical Inc | N/A | -292.7% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.